LumiraDx Announces Its Securities Will Be Suspended From Trading On Nasdaq At The Open Of Business On January 9th
Portfolio Pulse from Benzinga Newsdesk
LumiraDx Limited (NASDAQ:LMDX) announced that its securities will be suspended from Nasdaq trading on January 9, 2024, due to non-compliance with listing standards. The company had previously been warned about delisting for failing to meet the minimum bid price requirement. LumiraDx's appeal was withdrawn following the appointment of administrators for two subsidiaries and the sale of certain assets to Roche. Nasdaq confirmed the withdrawal and the upcoming suspension of trading.
January 07, 2024 | 8:24 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
LumiraDx Limited's securities will be suspended from Nasdaq due to non-compliance with listing standards, following the withdrawal of their appeal and the sale of assets to Roche.
The suspension of trading on Nasdaq is a significant negative event for LumiraDx, indicating severe compliance issues and potential financial instability. This will likely lead to a decrease in investor confidence and a negative impact on the stock price in the short term.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100